Cold urticaria with risk of anaphylaxis treated with omalizumab: a case report
Background: Omalizumab, which is a monoclonal anti-IgE antibody, has recently been used as an option in the treatment of inducible urticaria. Case report: We describe the case of a 46-year-old woman who was referred to the Department of Allergy and Immunology of “Hospital Civil de Guadalajara, Dr...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2021-02-01
|
| Series: | Revista Alergia México |
| Subjects: | |
| Online Access: | https://revistaalergia.mx/ojs/index.php/ram/article/view/744 |